US Patent 11491220 Methods of producing bioconjugates of
Patent 11491220 was granted and assigned to Janssen Pharmaceuticals on November, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 18, 2020
Date of Patent
November 8, 2022
Patent Application Number
16822403
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11491220 Methods of producing bioconjugates of
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.